Trademark Overview
On Tuesday, June 25, 1996, a trademark application was filed for INTEGRATED ONCOLOGY NETWORKS with the United States Patent and Trademark Office. The USPTO has given the INTEGRATED ONCOLOGY NETWORKS trademark a serial number of 75125388. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Saturday, October 23, 2004. This trademark is owned by CTC International, Inc.. The INTEGRATED ONCOLOGY NETWORKS trademark is filed in the Advertising, Business and Retail Services, Insurance & Financial Services, and Computer & Software Services & Scientific Services categories with the following description:
business administration and management services for cancer care providers; accounting services for cancer care providers; billing services for cancer care providers; personnel placement and recruitment in the health care field, namely, providing doctors and medical staff to cancer care providers; compiling, processing, and providing demographic, clinical, treatment, quality of life, financial, and related data regarding cancer patients; and business planning for cancer care providers
debt recovery and collection services for cancer care providers; financing services for cancer care providers; insurance consultation for cancer care providers; insurance claims administration and processing for cancer care providers; resolution of billing disputes for cancer care providers; and financial planning for cancer care providers
managed health care consultation for cancer care providers; managed health care services in the cancer care field; quality control services for cancer care providers; case management services in the cancer care field; computer consultation for cancer care providers; reviewing standards and practices to assure compliances with health care laws and regulations; organizing support groups for cancer patients; developing and promoting networks of cancer care providers; development and implementation of clinical protocols in the cancer care field; and providing cancer care providers with access to clinical research trials
